Effect of enteral feeding by formula which contains Bifidobacteria in low birth weight infants

Effect of enteral feeding by formula which contains Bifidobacteria in low birth weight infants - Bifidobacteria/LW study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024408

Enrollment

Registered

2019-12-31

Start date

2016-10-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low birth weight infants

Interventions

The infants receive either breast milk or premature formula which contains Bifidobacteria(test formula) if the mothers have inadequate milk production. The administration of test formula to each in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: LBWI(birthweight:>=1,000g and <2,000g, gestational age:>=28weeks) who is born in Toho university Ohmori medical center Parents receive enough information and consent to participate this trial

Exclusion criteria

Exclusion criteria: Who have sever respiratory ,renal ,cardiac or metabolic disease Who have chromosomal disease, congenital malformations Lack of parental consent Who are desided inappropriate to participate this trial

Design outcomes

Primary

Measure	Time frame
establishment of enteral feeding,defined as the postnatal day at which the amount of enteral feeding exceeded 100ml/kg/day	—

Secondary

Measure	Time frame
Growth(length,bodyweight, head circumference) Blood examination(calcium, phosphorus,ALP,iron,albumin,BUN,Hb) Morbidity(ricket,ROP,infection,anemin,NEC,CLD,PVL)	—

Countries

Japan

Contacts

Public ContactHiroko Arai

Toho University Ohmori Medical Center Department of Neonatology

araihiro@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026